| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.9M | +14.8% |
| Cost of Revenue | $6.7M | +48.9% |
| Gross Profit | $6.2M | -7.9% |
| R&D Expense | $3.6M | +32.0% |
| SG&A Expense | $11.0M | +4.4% |
| Operating Income | -$15.6M | -12.5% |
| Interest Expense | $156K | +38.1% |
| Pre-tax Income | -$15.1M | -54.4% |
| Net Income | -$15.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | -49.2% |
| Accounts Receivable | $4.6M | -0.8% |
| Inventory | $5.2M | +131.4% |
| Current Assets | $31.0M | -35.1% |
| Total Assets | $40.9M | -16.8% |
| Current Liabilities | $9.2M | +34.2% |
| Total Liabilities | $15.5M | +29.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | -31.7% |
| Capital Expenditures | $194K | +228.8% |
| Investing Cash Flow | -$5.2M | -8671.2% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$14.9M | -32.7% |
| -54.4% |
| EPS (Basic) | -$1.16 | -45.0% |
| EPS (Diluted) | -$1.16 | -31.8% |
| Stockholders' Equity |
| $25.4M |
| -31.6% |